Publication | Open Access
Nivolumab in previously treated patients with metastatic squamous NSCLC: Results of a European single-arm, phase 2 trial (CheckMate 171) including patients aged ≥70 years and with poor performance status
40
Citations
0
References
2017
Year
European Single-armPreclinical TherapeuticsUrologyMedicineCancer ManagementClinical TrialsMetastatic Squamous NsclcPharmacotherapyCancer TreatmentOncologyRadiation OncologyCheckmate 171Health Sciences
No additional data available for this publication yet. Check back later!